HCA Healthcare (NYSE:HCA) PT Set at $410.00 by Morgan Stanley

HCA Healthcare (NYSE:HCA) received a $410.00 price target from analysts at Morgan Stanley in a note issued to investors on Monday, MarketBeat Ratings reports. The brokerage presently has an “equal weight” rating on the stock. Morgan Stanley’s target price points to a potential upside of 12.39% from the stock’s current price.

A number of other research analysts also recently issued reports on HCA. Wells Fargo & Company upgraded HCA Healthcare from an “underweight” rating to an “equal weight” rating and lifted their price target for the company from $320.00 to $385.00 in a report on Thursday, May 29th. Royal Bank of Canada lowered their price objective on HCA Healthcare from $384.00 to $376.00 and set an “outperform” rating for the company in a research report on Monday, April 28th. Stephens raised HCA Healthcare to a “strong-buy” rating in a research report on Monday, June 2nd. Wall Street Zen raised HCA Healthcare from a “hold” rating to a “buy” rating in a research report on Monday, April 28th. Finally, Robert W. Baird reissued a “neutral” rating and issued a $336.00 price objective (down previously from $396.00) on shares of HCA Healthcare in a research report on Tuesday, April 15th. Seven research analysts have rated the stock with a hold rating, twelve have issued a buy rating and two have given a strong buy rating to the company’s stock. According to data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus target price of $392.47.

HCA Healthcare Trading Down 2.2%

HCA opened at $364.79 on Monday. HCA Healthcare has a 52 week low of $289.98 and a 52 week high of $417.14. The stock’s fifty day moving average is $356.11 and its two-hundred day moving average is $332.28. The company has a market capitalization of $87.76 billion, a P/E ratio of 16.60, a PEG ratio of 1.10 and a beta of 1.49. The company has a quick ratio of 0.97, a current ratio of 1.08 and a debt-to-equity ratio of 69.07.

HCA Healthcare (NYSE:HCA) last announced its quarterly earnings results on Friday, April 25th. The company reported $6.45 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $5.75 by $0.70. HCA Healthcare had a return on equity of 586.47% and a net margin of 8.16%. The business had revenue of $18.32 billion for the quarter, compared to the consensus estimate of $18.26 billion. During the same period last year, the business posted $5.36 EPS. The business’s revenue was up 5.7% compared to the same quarter last year. Analysts forecast that HCA Healthcare will post 24.98 earnings per share for the current year.

Insiders Place Their Bets

In other HCA Healthcare news, COO Jon M. Foster sold 15,698 shares of the business’s stock in a transaction that occurred on Tuesday, May 13th. The stock was sold at an average price of $369.32, for a total transaction of $5,797,585.36. Following the completion of the sale, the chief operating officer now directly owns 12,646 shares in the company, valued at approximately $4,670,420.72. The trade was a 55.38% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. 1.30% of the stock is owned by company insiders.

Institutional Investors Weigh In On HCA Healthcare

A number of large investors have recently made changes to their positions in HCA. Brighton Jones LLC purchased a new stake in shares of HCA Healthcare in the fourth quarter valued at approximately $1,021,000. Kestra Private Wealth Services LLC grew its position in shares of HCA Healthcare by 15.4% in the fourth quarter. Kestra Private Wealth Services LLC now owns 2,288 shares of the company’s stock valued at $687,000 after purchasing an additional 305 shares in the last quarter. Activest Wealth Management lifted its holdings in HCA Healthcare by 1,250.0% in the fourth quarter. Activest Wealth Management now owns 135 shares of the company’s stock valued at $40,000 after acquiring an additional 125 shares during the last quarter. Angeles Wealth Management LLC lifted its holdings in HCA Healthcare by 7.0% in the fourth quarter. Angeles Wealth Management LLC now owns 808 shares of the company’s stock valued at $243,000 after acquiring an additional 53 shares during the last quarter. Finally, Savant Capital LLC lifted its holdings in HCA Healthcare by 4.1% in the fourth quarter. Savant Capital LLC now owns 3,673 shares of the company’s stock valued at $1,102,000 after acquiring an additional 146 shares during the last quarter. 62.73% of the stock is currently owned by hedge funds and other institutional investors.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.